Proteomic profiling of proteases: Tools for granzyme degradomics

Expert Review of Proteomics

Volumn 7, Issue 3, 2010, Pages 347-359

  Van Domselaar, Robert ^a   De Poot, Stefanie AH ^a   Bovenschen, Niels ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

2D DIGE; Activity based probes; Granzyme; Isotopic labeling; Peptide libraries; Protease; Proteomics; Substrate

Indexed keywords

GRANZYME; PEPTIDE LIBRARY; PROTEINASE; SERINE PROTEINASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CYTOTOXIC LYMPHOCYTE; ENZYME SPECIFICITY; HUMAN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; GRANZYMES; HUMANS; PEPTIDE LIBRARY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; SUBSTRATE SPECIFICITY;

EID: 77953576157     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.10.24     Document Type: Review

References (94)

1. Lopez-Otin C, Overall CM. Protease degradomics: a new challenge for proteomics. Nat. Rev. Mol. Cell. Biol. 3(7), 509-519 (2002).
2. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4(7), 544-558 (2003).
3. Rawlings ND, Barrett AJ, Bateman A. MEROPS: the peptidase database. Nucleic Acids Res. 38, D227-233 (2010).
4. Khan AR, James MN. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Prot. Sci. 7(4), 815-836 (1998).
5. Citron M, Westaway D, Xia W et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid b-protein in both transfected cells and transgenic mice. Nat. Med. 3(1), 67-72 (1997).
6. Bowen DJ. Haemophilia A and haemophilia B: molecular insights. Mol. Pathol. 55(2), 127-144 (2002).
7. Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273(5279), 1236-1238 (1996).
8. Pham CT, Ivanovich JL, Raptis SZ, Zehnbauer B, Ley TJ. Papillon-Lefevre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J. Immunol. 173(12), 7277-7281 (2004).
9. Wang J, Zheng L, Lobito A et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98(1), 47-58 (1999).
10. Horikawa Y, Oda N, Cox NJ et al. Genetic variation in the gene encoding calpain-10 is associated with Type 2 diabetes mellitus. Nat. Genet. 26(2), 163-175 (2000).
11. Van Eerdewegh P, Little RD, Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418(6896), 426-430 (2002).
12. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat. Rev. Cancer 7(10), 800-808 (2007).
13. Barry M, Bleackley RC. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2(6), 401-409 (2002).
14. Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26, 389-420 (2008).
15. de Koning PJ, Kummer JA, Bovenschen N. Biology of granzyme M: a serine protease with unique features. Crit Rev. Immunol. 29(4), 307-315 (2009).
16. Mahrus S, Craik CS. Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells. Chem. Biol. 12(5), 567-577 (2005).
17. Boivin WA, Cooper DM, Hiebert PR, Granville DJ. Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab. Invest. 89(11), 1195-1220 (2009).
18. Buzza MS, Bird PI. Extracellular granzymes: current perspectives. Biol. Chem. 387(7), 827-837 (2006).
19. Roos A, Ramwadhdoebe TH, Nauta AJ, Hack CE, Daha MR. Therapeutic inhibition of the early phase of complement activation. Immunobiology 205(4-5), 595-609 (2002).
20. Thomas HE, Trapani JA, Kay TW. The role of perforin and granzymes in diabetes. Cell. Death Differ. 17(4), 577-585 (2009).
21. Turk B. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov. 5(9), 785-799 (2006).
22. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27(2), 157-162 (1967).
23. Matthews DJ, Wells JA. Substrate phage: selection of protease substrates by monovalent phage display. Science 260(5111), 1113-1117 (1993).
24. Kaiserman D, Bird CH, Sun J et al. The major human and mouse granzymes are structurally and functionally divergent. J. Cell. Biol. 175(4), 619-630 (2006).
25. Cullen SP, Adrain C, Luthi AU, Duriez PJ, Martin SJ. Human and murine granzyme B exhibit divergent substrate preferences. J. Cell. Biol. 176(4), 435-444 (2007).
26. Boulware KT, Daugherty PS. Protease specificity determination by using cellular libraries of peptide substrates (CLiPS). Proc. Natl Acad. Sci. USA 103(20), 7583-7588 (2006).
27. Bovenschen N, Quadir R, van den Berg AL et al. Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A. J. Biol. Chem. 284(6), 3504-3512 (2009).
28. Bell JK, Goetz DH, Mahrus S, Harris JL, Fletterick RJ, Craik CS. The oligomeric structure of human granzyme A is a determinant of its extended substrate specificity. Nat. Struct. Biol. 10(7), 527-534 (2003).
29. Fan Z, Beresford PJ, Zhang D et al. Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat. Immunol. 4(2), 145-153 (2003).
30. Schilling O, Overall CM. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat. Biotechnol. 26(6), 685-694 (2008).
31. Pinilla C, Appel JR, Blanc P, Houghten RA. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. Biotechniques 13(6), 901-905 (1992).
32. Backes BJ, Harris JL, Leonetti F, Craik CS, Ellman JA. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat. Biotechnol. 18(2), 187-193 (2000).
33. Harris JL, Peterson EP, Hudig D, Thornberry NA, Craik CS. Definition and redesign of the extended substrate specificity of granzyme B. J. Biol. Chem. 273(42), 27364-27373 (1998).
34. Mahrus S, Kisiel W, Craik CS. Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B. J. Biol. Chem. 279(52), 54275-54282 (2004).
35. Thornberry NA, Rano TA, Peterson EP et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272(29), 17907-17911 (1997).
36. Krishnaswamy S. Exosite-driven substrate specificity and function in coagulation. J. Thromb. Haemost. 3(1), 54-67 (2005).
37. Overall CM. Matrix metalloproteinase substrate binding domains, modules and exosites. Overview and experimental strategies. Methods Mol. Biol. 151, 79-120 (2001).
38. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250(10), 4007-4021 (1975).
39. Bovenschen N, de Koning PJ, Quadir R et al. NK cell protease granzyme M targets a-tubulin and disorganizes the microtubule network. J. Immunol. 180(12), 8184-8191 (2008).
40. Adrain C, Murphy BM, Martin SJ. Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B. J. Biol. Chem. 280(6), 4663-4673 (2005).
41. Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 382(3), 669-678 (2005).
42. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18(11), 2071-2077 (1997).
43. Bredemeyer AJ, Lewis RM, Malone JP et al. A proteomic approach for the discovery of protease substrates. Proc. Natl Acad. Sci. USA 101(32), 11785-11790 (2004).
44. Metkar SS, Menaa C, Pardo J et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29(5), 720-733 (2008).
45. Dix MM, Simon GM, Cravatt BF. Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 134(4), 679-691 (2008).
46. Thiede B, Treumann A, Kretschmer A, Sohlke J, Rudel T. Shotgun proteome analysis of protein cleavage in apoptotic cells. Proteomics 5(8), 2123-2130 (2005).
47. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17(10), 994-999 (1999).
48. Zhang R, Sioma CS, Wang S, Regnier FE. Fractionation of isotopically labeled peptides in quantitative proteomics. Anal. Chem. 73(21), 5142-5149 (2001).
49. Zhang R, Regnier FE. Minimizing resolution of isotopically coded peptides in comparative proteomics. J. Proteome Res. 1(2), 139-147 (2002).
50. Zhou H, Ranish JA, Watts JD, Aebersold R. Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. Nat. Biotechnol. 20(5), 512-515 (2002).
51. Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3(12), 1154-1169 (2004).
52. Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1(5), 376-386 (2002).
53. Butler GS, Dean RA, Tam EM, Overall CM. Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol. Cell. Biol. 28(15), 4896-4914 (2008).
54. Tam EM, Morrison CJ, Wu YI, Stack MS, Overall CM. Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl Acad. Sci. USA 101(18), 6917-6922 (2004).
55. Dean RA, Overall CM. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol. Cell. Proteomics 6(4), 611-623 (2007).
56. McDonald L, Robertson DH, Hurst JL, Beynon RJ. Positional proteomics: selective recovery and analysis of N-terminal proteolytic peptides. Nat. Methods 2(12), 955-957 (2005).
57. Brown JL, Roberts WK. Evidence that approximately eighty per cent of the soluble proteins from Ehrlich ascites cells are Na-acetylated. J. Biol. Chem. 251(4), 1009-1014 (1976).
58. Gevaert K, Goethals M, Martens L et al. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol. 21(5), 566-569 (2003).
59. Staes A, Van Damme P, Helsens K, Demol H, Vandekerckhove J, Gevaert K. Improved recovery of proteome-informative, protein N-terminal peptides by combined fractional diagonal chromatography (COFRADIC). Proteomics 8(7), 1362-1370 (2008).
60. Van Damme P, Maurer-Stroh S, Plasman K et al. Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs. Mol. Cell. Proteomics 8(2), 258-272 (2009).
61. Mirgorodskaya OA, Kozmin YP, Titov MI, Korner R, Sonksen CP, Roepstorff P. Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun. Mass Spectrom. 14(14), 1226-1232 (2000).
62. Van Damme P, Martens L, Van Damme J et al. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat. Methods 2(10), 771-777 (2005).
63. Kaiserman D, Buckle AM, Van Damme P et al. Structure of granzyme C reveals an unusual mechanism of protease autoinhibition. Proc. Natl Acad. Sci. USA 106(14), 5587-5592 (2009).
64. McDonald L, Beynon RJ. Positional proteomics: preparation of amino-terminal peptides as a strategy for proteome simplification and characterization. Nat. Protoc. 1(4), 1790-1798 (2006).
65. Doucet A, Overall CM. Protease proteomics: revealing protease in vivo functions using systems biology approaches. Mol. Aspects Med. 29(5), 339-358 (2008).
66. Kleifeld O, Doucet A, auf dem Keller U et al. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat. Biotechnol. 28(3), 281-288 (2010).
67. Timmer JC, Enoksson M, Wildfang E et al. Profiling constitutive proteolytic events in vivo. Biochem. J. 407(1), 41-48 (2007).
68. Enoksson M, Li J, Ivancic MM et al. Identification of proteolytic cleavage sites by quantitative proteomics. J. Proteome Res. 6(7), 2850-2858 (2007).
69. Chang TK, Jackson DY, Burnier JP, Wells JA. Subtiligase: a tool for semisynthesis of proteins. Proc. Natl Acad. Sci. USA 91(26), 12544-12548 (1994).
70. Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134(5), 866-876 (2008).
71. Xu G, Shin SB, Jaffrey SR. Global profiling of protease cleavage sites by chemoselective labeling of protein N-termini. Proc. Natl Acad. Sci. USA 106(46), 19310-19315 (2009).
72. Jessani N, Liu Y, Humphrey M, Cravatt BF. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc. Natl Acad. Sci. USA 99(16), 10335-10340 (2002).
73. Kidd D, Liu Y, Cravatt BF. Profiling serine hydrolase activities in complex proteomes. Biochemistry 40(13), 4005-4015 (2001).
74. Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: the serine hydrolases. Proc. Natl Acad. Sci. USA 96(26), 14694-14699 (1999).
75. Patricelli MP, Giang DK, Stamp LM, Burbaum JJ. Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes. Proteomics 1(9), 1067-1071 (2001).
76. Williams EB, Krishnaswamy S, Mann KG. Zymogen/enzyme discrimination using peptide chloromethyl ketones. J. Biol. Chem. 264(13), 7536-7545 (1989).
77. Borodovsky A, Ovaa H, Kolli N et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 9(10), 1149-1159 (2002).
78. Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 16(9), 2271-2281 (1997).
79. Greenbaum D, Medzihradszky KF, Burlingame A, Bogyo M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7(8), 569-581 (2000).
80. Kato D, Boatright KM, Berger AB et al. Activity-based probes that target diverse cysteine protease families. Nat. Chem. Biol. 1(1), 33-38 (2005).
81. Nicholson DW, Ali A, Thornberry NA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376(6535), 37-43 (1995).
82. Thornberry NA, Peterson EP, Zhao JJ, Howard AD, Griffin PR, Chapman KT. Inactivation of interleukin-1b converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry 33(13), 3934-3940 (1994).
83. Bogyo M, McMaster JS, Gaczynska M, Tortorella D, Goldberg AL, Ploegh H. Covalent modification of the active site threonine of proteasomal b subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc. Natl Acad. Sci. USA 94(13), 6629-6634 (1997).
84. Kessler BM, Tortorella D, Altun M et al. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic b-subunits. Chem. Biol. 8(9), 913-929 (2001).
85. Chan EW, Chattopadhaya S, Panicker RC, Huang X, Yao SQ. Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases. J. Am. Chem. Soc. 126(44), 14435-14446 (2004).
86. Saghatelian A, Jessani N, Joseph A, Humphrey M, Cravatt BF. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl Acad. Sci. USA 101(27), 10000-10005 (2004).
87. Fonovic M, Bogyo M. Activity-based probes as a tool for functional proteomic analysis of proteases. Expert Rev. Proteomics 5(5), 721-730 (2008).
88. Winssinger N, Ficarro S, Schultz PG, Harris JL. Profiling protein function with small molecule microarrays. Proc. Natl Acad. Sci. USA 99(17), 11139-11144 (2002).
89. Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat. Chem. Biol. 3(10), 668-677 (2007).
90. Edgington LE, Berger AB, Blum G et al. Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat. Med. 15(8), 967-973 (2009).
91. Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 4, 222 (2008).
92. Shields DJ, Niessen S, Murphy EA et al. RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia. Proc. Natl Acad. Sci. USA 107(5), 2189-2194 (2010).
93. Vogtle FN, Wortelkamp S, Zahedi RP et al. Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability. Cell 139(2), 428-439 (2009).
94. Timmer JC, Zhu W, Pop C et al. Structural and kinetic determinants of protease substrates. Nat. Struct. Mol. Biol. 16(10), 1101-1108 (2009).